Downregulation of mitogen-activated protein kinases in human colon cancers

Anticancer Research

Volumn 20, Issue 1 A, 2000, Pages 75-83

  Wang, Qingding ^a   Ding, Qingming ^b   Dong, Zizheng ^c   Ehlers, Richard A ^e   Evers, B Mark ^d  

^a BEIJING INSTITUTE OF PHARMACOLOGY AND TOXICOLOGY   (China)

^b BEIJING INSTITUTE OF RADIATION MEDICINE   (China)

^c BEIJING INSTITUTE OF BIOTECHNOLOGY   (China)

^d University of Texas Medical Branch School of Medicine   (United States)

^e NONE

Author keywords

Autophosphorylation; Colorectal cancer; JNK; Mitogen activated protein kinases; p38

Indexed keywords

ISOENZYME; MITOGEN ACTIVATED PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN;

ARTICLE; CLINICAL ARTICLE; COLON CARCINOGENESIS; COLON MUCOSA; COLORECTAL CANCER; CONTROLLED STUDY; DOWN REGULATION; ENZYME ASSAY; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; PRIORITY JOURNAL;

ADENOCARCINOMA; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; COLONIC NEOPLASMS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYCOGEN SYNTHASE KINASE 3; HUMANS; INTESTINAL MUCOSA; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASE 6; MITOGEN-ACTIVATED PROTEIN KINASES; NEOPLASM PROTEINS; NEOPLASM STAGING; P38 MITOGEN-ACTIVATED PROTEIN KINASES;

EID: 0034113717     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Landis SH, Murray T, Bolden S, Wingo PA: Cancer Statistics, 1998. CA Cancer J Clin 48: 6-29, 1998.
2. Fearon ER, Vogelstein B: A genetic model for colorectal tumorigenesis. Cell 61: 759-767, 1990.
3. Vogelstein B, Kinzler KW: The multistep nature of cancer. Trends Genet 9: 138-141, 1993.
4. Bos JL, Fearon ER, Hamilton SR, et al: Prevalence of ras gene mutations in human colorectal cancer. Nature 327: 293-297, 1987.
5. Barbacid M: ras genes. Ann Rev Biochem 56: 779-827, 1987.
6. Bourne HR, Sanders DA, McCormick F: The GTPase superfamily: conserved structure and molecular mechanism. Nature 349: 117-127, 1991.
7. Lowy DR: Function and regulation of ras. Ann Rev Biochem 62: 851-891, 1993.
8. Bollag G, McCormick F: Regulators and effectors of ras proteins. Ann Rev Cell Biol 7: 601-632, 1991.
9. Vojtek AB, Der CJ: Increasing complexity of the Ras signaling pathway. J Biol 273: 19925-19928, 1998.
10. Seger R, Krebs EG: The MAPK signaling cascade. FASEB J 9: 726-735, 1995.
11. Cano E, Mahadevan LC: Parallel signal processing among mammalian MAPKs. TIBS 20: 117-122, 1995.
12. Cobb MH, Goldsmith EJ: How MAP kinases are regulated. J Biol Chem 270: 14843-14846, 1995.
13. Marais R, Marshall CJ: Control of the ERK MAP kinase cascade by ras and raf. Cancer Surveys 27: 101-125, 1996.
14. Whitmarsh AJ, Davis RJ: Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways. Mol Med 74: 589-607, 1996.
15. Minden A, Karin M: Regulation and function of the JNK subgroup of MAP kinases. Biochimica et Biophysics Acta 1333: F85-F104, 1997.
16. Gutkind JS: The pathways connecting G protein-coupled receptors to the nucleus through divergent mitogen-activated protein kinase cascades. J Biol Chem 273: 1839-1842, 1998.
17. Pelech SL, Sanghera JS: MAP kinases: charting the regulatory pathways. Science 257: 1355-1356, 1992.
18. Blumer KJ, Johnson GL: Diversity in function and regulation of MAP kinase pathways. Trends Biochem Sci 19: 236-240, 1994.
19. Karin M: Signal transduction from cell surface to nucleus in development and disease. FASEB J 6: 2581-2590, 1992.
20. Bos JL: The ras gene family and human carcinogenesis. Mutat Res 195: 255-271, 1988.
21. Mansour SJ, Matten WT, Hermann AS, et al. Transformation of mammalian cells by constitutively active MAP kinase kinase. Science 265: 966-970, 1994.
22. Brunet A, Pages G, Pouyssegur J: Constitutively active mutants of MAP kinase kinase (MEK1) induce growth factor-relaxation and oncogenicity when expressed in fibroblasts. Oncogene 9: 3379-3387, 1994.
23. Cowley S, Paterson H, Kemp P, Marshall CJ: Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 373 cells. Cell 77: 841-852, 1994.
24. Glarakis IS, Savva S, Spandidos DA: Activation of the ras genes in malignant and premalignant colorectal tumors. Oncol Rep 5: 1451-1454, 1998.
25. Webb CP, Van Aelst L, Wigler MH, Vande Woude GF: Signaling pathways in Ras-mediated tumorigenicity and metastasis. Proc Natl Acad Sci 95: 8773-8778, 1998.
26. Licato LL, Keku TO, Wurzelmann JJ, et al: In vivo activation of mitogen-activated protein kinases in rat intestinal neoplasia. Gastroenterology 113: 1589-1598, 1997.
27. English JM, Pearson G, Baer R, Cobb MH: Identification of substrates and regulators of the mitogen-activated protein kinase ERK5 using chimeric protein kinases. J Biol Chem 273: 3854-3860, 1998.
28. Cheng M, Boulton TG, Cobb MH: ERK3 is a constitutively nuclear protein kinase. J Biol Chem 271: 8951-8958, 1996.
29. Astler VB, Coller FA: The prognostic significance of direct extension of carcinoma of the colon and rectum. Ann Surg 139: 846-852, 1954.
30. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
31. Evers BM, Ko TC, Li J, Thompson EA: Cell cycle protein suppression and p21 induction in differentiating Caco-2 cells. Am J Physiol 271: G722-G727, 1996.
32. Ding QM, Ko TC, Evers BM: Caco-2 intestinal cell differentiation is associated with G1 arrest and suppression of CDK2 and CDK4. Am J Physiol 275: C1193-C1200, 1998.
33. Gonzalez FA, Raden DL, Rigby MR, Davis RJ: Heterogeneous expression of four MAP kinase isoforms in human tissues. FEBS Lett 304: 170-178, 1992.
34. Zhu AX, Zhao Y, Moller DE, Flier JS: Cloning and characterization of p97MAPK, a novel human homolog of rat ERK-3. Mol Cell Biol 14: 8202-8211, 1994.
35. Sauma S, Friedman E: Increased expression of protein kinase C beta activates ERK3. J Biol Chem 271: 11422-11426, 1996.
36. Attar BM, Atten MJ, Holian O: MAPK activity is down-regulated in human colon adenocarcinoma: correlation with PKC activity. Anticancer Res 16: 395-399, 1996.
37. Licato LL, Brenner DA: Analysis of signaling protein kinases in human colon or colorectal carcinomas. Dig Dis Sci 43: 1454-1464, 1998.
38. Loda M, Capodicci P, Mishra R, et al: Expression of mitogenactivated protein kinase phosphatase-1 in the early phases of human epithelial carcinogenesis. Am J Pathol 149: 1553-1564, 1996.
39. Atten MJ, Attar BM, Holian O: Decreased MAP kinase activity in human gastric adenocarcinoma. Biochem Biophys Res Commun 212: 1001-1006, 1995.
40. Bang YJ, Kwon JH, Kang SH, Kim JW, Yang YC: Increased MAPK activity and MKP-1 overexpression in human gastric adenocarcinoma. Biochem Biophys Res Commun 250: 43-47, 1998.
41. Sivaraman VS, Wang H, Nuovo GJ, Malbon CC: Hyperexpression of mitogen-activated protein kinase in human breast cancer. J Clin Invest 99: 1478-1483, 1997.
42. Oka H, Chatani LY, Hoshino R. et al: Constitutive activation of mitogen-activated protein (MAP) kinases in human renal cell carcinoma. Cancer Res 55: 4182-4187, 1995.
43. Thurnherr N, Deschner EE, Stonehill EH, Lipkin M: Induction of adenocarcinomas of the colon in mice by weekly injections of DMH. Cancer Res 33: 940-945, 1973.
44. Simanowski UA, Wright NA, Seitz HK: Mucosal cellular regeneration and colorectal carcinogenesis. In: Seitz HK, Simanowski UA, Wright NA. Colorectal cancer: from pathogenesis to prevention? New York: Springer-Verlag, 1989: 225-236.
45. LaMont JL, O'Gorman TA: Experimental colon cancer. Gastroenterology 75: 1157-1169, 1978.
46. McGarrity TJ, Peiffer LP, Colony PC: Cellular proliferation in proximal and distal rat colon during 1,2-dimethylhydrazine-induced carcinogenesis. Gastroenterology 95: 343-348, 1988.
47. Freeman HJ, Kim Y, Kim YS: Glycoprotein metabolism in normal proximal and distal rat colon and changes associated with 1,2-dimethylhydrazine-induced colonic neoplasia. Cancer Res 38: 3385-3390, 1978.
48. Naito Y: Studies on experimental colon tumorigenesis in rats I. Strain differences in incidence, location and tumor types of 1, 2-dimethylhydrazine-induced tumors. Hiroshima J Med Sci 30: 355-362, 1981.
49. Hunter T, Plowman GD: The protein kinases of budding yeast: six and more. Trends Biochem Sci 22; 18-22, 1997.
50. Zhou G, Bao ZQ, Dixon JE: Components of a new human protein kinase signal transduction pathway. J Biol Chem 270; 12665-12669, 1995
51. Lechner C, Zahalka MA, Giot JF, Moller NP, Ullrich A: ERK6, a mitogen-activated protein kinase involved in C2C12 myoblast differentiation. Proc Natl Acad Sci USA 93: 4355-4359, 1996.
52. Li Z, Jiang Y, Ulevitch RJ, Han J: The primary structure of p38 gamma: a new member of p38 group of MAP kinases. Biochem Biophys Res Commun 228: 334-340, 1996.